| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart | 72 | 2011 | 850 | 4.670 |
Why?
|
| Cell Adhesion Molecules | 24 | 2019 | 199 | 4.300 |
Why?
|
| Tissue Engineering | 27 | 2016 | 212 | 4.160 |
Why?
|
| Mesoderm | 46 | 2019 | 231 | 3.230 |
Why?
|
| Heart Valves | 22 | 2019 | 171 | 3.080 |
Why?
|
| Chick Embryo | 72 | 2017 | 379 | 2.110 |
Why?
|
| Myocardium | 47 | 2012 | 1204 | 1.980 |
Why?
|
| Endocardium | 23 | 2019 | 101 | 1.590 |
Why?
|
| Animals | 159 | 2019 | 20881 | 1.490 |
Why?
|
| Extracellular Matrix | 24 | 2019 | 493 | 1.440 |
Why?
|
| Organogenesis | 5 | 2019 | 49 | 1.260 |
Why?
|
| Stem Cells | 12 | 2016 | 248 | 1.200 |
Why?
|
| Hyaluronic Acid | 17 | 2017 | 206 | 1.150 |
Why?
|
| Tissue Scaffolds | 7 | 2015 | 111 | 1.120 |
Why?
|
| Morphogenesis | 25 | 2019 | 159 | 1.030 |
Why?
|
| Cell Differentiation | 37 | 2021 | 1034 | 0.990 |
Why?
|
| Signal Transduction | 20 | 2021 | 2689 | 0.960 |
Why?
|
| Hyaluronan Receptors | 9 | 2021 | 142 | 0.930 |
Why?
|
| Bioreactors | 5 | 2011 | 65 | 0.910 |
Why?
|
| Myocytes, Cardiac | 9 | 2016 | 442 | 0.890 |
Why?
|
| Mitral Valve Prolapse | 6 | 2019 | 40 | 0.830 |
Why?
|
| Mice | 41 | 2019 | 8474 | 0.820 |
Why?
|
| Transforming Growth Factor beta | 12 | 2016 | 384 | 0.820 |
Why?
|
| Embryonic Induction | 11 | 1999 | 19 | 0.800 |
Why?
|
| Gene Expression Regulation, Developmental | 13 | 2013 | 328 | 0.800 |
Why?
|
| Cell Movement | 29 | 2016 | 630 | 0.760 |
Why?
|
| Fibroblasts | 12 | 2016 | 902 | 0.700 |
Why?
|
| Atrioventricular Node | 5 | 2011 | 39 | 0.680 |
Why?
|
| Artificial Organs | 3 | 2003 | 3 | 0.670 |
Why?
|
| Cell Culture Techniques | 6 | 2016 | 189 | 0.670 |
Why?
|
| Bioprinting | 3 | 2015 | 11 | 0.670 |
Why?
|
| Actin Cytoskeleton | 2 | 2019 | 37 | 0.660 |
Why?
|
| p21-Activated Kinases | 1 | 2019 | 14 | 0.660 |
Why?
|
| Integrin beta1 | 1 | 2019 | 48 | 0.650 |
Why?
|
| Heart Valve Diseases | 6 | 2013 | 123 | 0.640 |
Why?
|
| Biotechnology | 2 | 2009 | 34 | 0.640 |
Why?
|
| Spheroids, Cellular | 7 | 2014 | 45 | 0.630 |
Why?
|
| Microfilament Proteins | 4 | 2012 | 102 | 0.610 |
Why?
|
| Cell Physiological Phenomena | 1 | 2017 | 19 | 0.610 |
Why?
|
| Cytological Techniques | 1 | 2017 | 23 | 0.600 |
Why?
|
| Cicatrix | 2 | 2016 | 60 | 0.590 |
Why?
|
| Extremities | 7 | 1993 | 49 | 0.580 |
Why?
|
| Cells, Cultured | 31 | 2016 | 2673 | 0.570 |
Why?
|
| Endothelium | 18 | 2004 | 98 | 0.560 |
Why?
|
| Mitral Valve | 7 | 2019 | 166 | 0.550 |
Why?
|
| Biocompatible Materials | 5 | 2016 | 247 | 0.550 |
Why?
|
| Integrins | 3 | 2019 | 115 | 0.540 |
Why?
|
| Gap Junctions | 1 | 2016 | 29 | 0.530 |
Why?
|
| Developmental Biology | 2 | 2007 | 3 | 0.530 |
Why?
|
| Heart Injuries | 1 | 2016 | 25 | 0.530 |
Why?
|
| Extracellular Matrix Proteins | 6 | 2005 | 144 | 0.500 |
Why?
|
| Immunohistochemistry | 19 | 2013 | 1174 | 0.500 |
Why?
|
| Culture Techniques | 14 | 2005 | 65 | 0.480 |
Why?
|
| Collagen | 17 | 2013 | 636 | 0.480 |
Why?
|
| Anatomy | 2 | 2006 | 36 | 0.470 |
Why?
|
| Neural Crest | 9 | 2005 | 58 | 0.470 |
Why?
|
| Humans | 67 | 2021 | 68618 | 0.470 |
Why?
|
| Contractile Proteins | 2 | 2012 | 17 | 0.470 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2016 | 182 | 0.440 |
Why?
|
| Endothelial Cells | 6 | 2019 | 384 | 0.440 |
Why?
|
| Cell Adhesion | 11 | 2014 | 324 | 0.430 |
Why?
|
| Regeneration | 5 | 2013 | 105 | 0.420 |
Why?
|
| Endoderm | 3 | 2003 | 37 | 0.410 |
Why?
|
| Filamins | 4 | 2018 | 17 | 0.390 |
Why?
|
| Zebrafish Proteins | 3 | 2015 | 100 | 0.380 |
Why?
|
| Endothelium, Vascular | 6 | 2006 | 371 | 0.380 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2014 | 223 | 0.380 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2007 | 43 | 0.380 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2017 | 126 | 0.380 |
Why?
|
| Connective Tissue | 4 | 2013 | 61 | 0.380 |
Why?
|
| Heart Defects, Congenital | 6 | 2012 | 596 | 0.370 |
Why?
|
| Printing, Three-Dimensional | 3 | 2016 | 31 | 0.370 |
Why?
|
| Colonic Neoplasms | 5 | 2021 | 299 | 0.370 |
Why?
|
| Cell Survival | 9 | 2019 | 901 | 0.360 |
Why?
|
| Cell Line | 10 | 2017 | 1752 | 0.360 |
Why?
|
| Heart Conduction System | 3 | 2007 | 119 | 0.340 |
Why?
|
| Models, Biological | 10 | 2019 | 981 | 0.330 |
Why?
|
| Biomechanical Phenomena | 3 | 2007 | 368 | 0.330 |
Why?
|
| Mutation | 7 | 2018 | 1213 | 0.330 |
Why?
|
| Nanoparticles | 3 | 2009 | 254 | 0.330 |
Why?
|
| Cardiovascular System | 2 | 2008 | 85 | 0.320 |
Why?
|
| Avian Proteins | 4 | 2007 | 23 | 0.320 |
Why?
|
| Biomedical Engineering | 1 | 2008 | 20 | 0.310 |
Why?
|
| Coturnix | 6 | 2006 | 22 | 0.310 |
Why?
|
| Glycosaminoglycans | 9 | 2007 | 88 | 0.310 |
Why?
|
| Gels | 4 | 2007 | 55 | 0.310 |
Why?
|
| Autocrine Communication | 3 | 2017 | 37 | 0.300 |
Why?
|
| Cell Aggregation | 7 | 2008 | 28 | 0.300 |
Why?
|
| Coculture Techniques | 6 | 2013 | 147 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 9 | 2019 | 2791 | 0.290 |
Why?
|
| Growth Substances | 2 | 2003 | 77 | 0.290 |
Why?
|
| Nanotechnology | 1 | 2008 | 109 | 0.290 |
Why?
|
| Organ Culture Techniques | 5 | 2003 | 122 | 0.290 |
Why?
|
| Fibrillar Collagens | 1 | 2007 | 49 | 0.290 |
Why?
|
| Computer Peripherals | 2 | 2003 | 5 | 0.280 |
Why?
|
| Printing | 2 | 2003 | 9 | 0.280 |
Why?
|
| Myofibroblasts | 2 | 2017 | 60 | 0.280 |
Why?
|
| Regenerative Medicine | 1 | 2006 | 17 | 0.270 |
Why?
|
| Cyclooxygenase 2 | 4 | 2013 | 160 | 0.270 |
Why?
|
| Cell Proliferation | 8 | 2014 | 1174 | 0.270 |
Why?
|
| Computer-Aided Design | 3 | 2015 | 101 | 0.260 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 1293 | 0.260 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2006 | 36 | 0.260 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 216 | 0.250 |
Why?
|
| Cytoplasm | 1 | 2005 | 155 | 0.250 |
Why?
|
| RNA, Messenger | 13 | 2015 | 1664 | 0.250 |
Why?
|
| Drosophila melanogaster | 1 | 2005 | 80 | 0.250 |
Why?
|
| Mice, Knockout | 7 | 2019 | 1692 | 0.240 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 58 | 0.240 |
Why?
|
| Ventricular Remodeling | 1 | 2007 | 318 | 0.240 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 247 | 0.240 |
Why?
|
| Cell Communication | 2 | 2016 | 116 | 0.230 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 1998 | 36 | 0.230 |
Why?
|
| Embryonic Development | 5 | 2008 | 100 | 0.230 |
Why?
|
| Aging | 1 | 2010 | 911 | 0.230 |
Why?
|
| Pulmonary Fibrosis | 2 | 2017 | 157 | 0.230 |
Why?
|
| Societies, Medical | 1 | 2006 | 403 | 0.230 |
Why?
|
| Soybean Proteins | 2 | 1995 | 11 | 0.230 |
Why?
|
| Phenotype | 8 | 2018 | 947 | 0.230 |
Why?
|
| Tissue Transplantation | 1 | 2003 | 9 | 0.220 |
Why?
|
| Rats | 16 | 2017 | 5300 | 0.220 |
Why?
|
| Awards and Prizes | 1 | 2003 | 27 | 0.220 |
Why?
|
| Absorbable Implants | 1 | 2003 | 29 | 0.220 |
Why?
|
| Nuclear Proteins | 2 | 2003 | 271 | 0.220 |
Why?
|
| Heart Diseases | 1 | 2005 | 276 | 0.220 |
Why?
|
| Fibroblast Growth Factors | 1 | 2003 | 51 | 0.220 |
Why?
|
| Microscopy, Confocal | 8 | 2016 | 337 | 0.220 |
Why?
|
| Fibronectins | 7 | 1997 | 130 | 0.210 |
Why?
|
| Pericardium | 3 | 2008 | 97 | 0.210 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 195 | 0.210 |
Why?
|
| Ectoderm | 3 | 1993 | 8 | 0.210 |
Why?
|
| Cell Lineage | 4 | 2012 | 146 | 0.210 |
Why?
|
| Endocardial Cushion Defects | 3 | 2000 | 11 | 0.210 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2014 | 27 | 0.200 |
Why?
|
| Heart Atria | 8 | 2019 | 206 | 0.200 |
Why?
|
| Blood Vessels | 3 | 2010 | 102 | 0.200 |
Why?
|
| Microscopy, Electron, Scanning | 14 | 2008 | 236 | 0.200 |
Why?
|
| Glycoproteins | 5 | 2011 | 238 | 0.200 |
Why?
|
| Adenoviridae | 4 | 2007 | 295 | 0.200 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2021 | 3 | 0.190 |
Why?
|
| Stress, Mechanical | 2 | 2016 | 208 | 0.190 |
Why?
|
| Genetic Therapy | 3 | 2009 | 291 | 0.190 |
Why?
|
| Epithelial Cells | 5 | 2009 | 431 | 0.190 |
Why?
|
| Myofibrils | 3 | 2016 | 35 | 0.190 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 411 | 0.190 |
Why?
|
| Culture Media, Conditioned | 7 | 1999 | 78 | 0.190 |
Why?
|
| Embryonic and Fetal Development | 3 | 1997 | 74 | 0.190 |
Why?
|
| Robotics | 3 | 2011 | 56 | 0.190 |
Why?
|
| In Vitro Techniques | 5 | 2006 | 765 | 0.190 |
Why?
|
| Actins | 3 | 1997 | 249 | 0.190 |
Why?
|
| Cadherins | 3 | 2019 | 93 | 0.180 |
Why?
|
| Heart Septum | 4 | 1999 | 84 | 0.180 |
Why?
|
| Computer Simulation | 4 | 2009 | 706 | 0.180 |
Why?
|
| Chickens | 5 | 2008 | 232 | 0.180 |
Why?
|
| Ambystoma | 3 | 1989 | 33 | 0.180 |
Why?
|
| Alginates | 3 | 2015 | 35 | 0.180 |
Why?
|
| In Situ Hybridization | 7 | 2007 | 201 | 0.180 |
Why?
|
| Gastrula | 2 | 1997 | 17 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 1 | 2021 | 84 | 0.180 |
Why?
|
| Heart Ventricles | 11 | 2009 | 738 | 0.180 |
Why?
|
| Bone Morphogenetic Protein 2 | 4 | 2019 | 57 | 0.170 |
Why?
|
| MicroRNAs | 2 | 2016 | 447 | 0.170 |
Why?
|
| Embryonic Stem Cells | 2 | 2017 | 40 | 0.170 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 940 | 0.170 |
Why?
|
| Lectins | 3 | 1995 | 81 | 0.170 |
Why?
|
| Microscopy, Electron | 13 | 1997 | 351 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2010 | 116 | 0.170 |
Why?
|
| Glycoconjugates | 2 | 1989 | 22 | 0.170 |
Why?
|
| Hedgehog Proteins | 1 | 2019 | 38 | 0.160 |
Why?
|
| Cardiac Myosins | 1 | 1998 | 12 | 0.160 |
Why?
|
| Pluripotent Stem Cells | 1 | 2019 | 42 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 5 | 2000 | 511 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2006 | 282 | 0.160 |
Why?
|
| Cilia | 1 | 2019 | 94 | 0.160 |
Why?
|
| Blastoderm | 1 | 1997 | 1 | 0.150 |
Why?
|
| 3T3 Cells | 2 | 2012 | 124 | 0.150 |
Why?
|
| PC12 Cells | 1 | 2017 | 36 | 0.150 |
Why?
|
| Fibrosis | 3 | 2010 | 371 | 0.150 |
Why?
|
| Bundle of His | 2 | 2008 | 21 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 468 | 0.150 |
Why?
|
| Tretinoin | 2 | 1997 | 92 | 0.150 |
Why?
|
| Pulmonary Veins | 2 | 2000 | 56 | 0.150 |
Why?
|
| Embryo, Mammalian | 6 | 2019 | 176 | 0.140 |
Why?
|
| Blotting, Western | 5 | 2010 | 954 | 0.140 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2017 | 42 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 2324 | 0.140 |
Why?
|
| Chondroitin Sulfates | 4 | 1989 | 44 | 0.140 |
Why?
|
| NADPH Oxidases | 1 | 2017 | 80 | 0.140 |
Why?
|
| Staining and Labeling | 5 | 2006 | 144 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 147 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2007 | 127 | 0.140 |
Why?
|
| Cell Fusion | 3 | 2013 | 23 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 66 | 0.140 |
Why?
|
| Quail | 7 | 2008 | 27 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2013 | 33 | 0.140 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 21 | 0.130 |
Why?
|
| Plant Lectins | 2 | 1995 | 20 | 0.130 |
Why?
|
| Paracrine Communication | 1 | 2016 | 31 | 0.130 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 18 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2012 | 219 | 0.130 |
Why?
|
| Heart Failure | 1 | 2005 | 1180 | 0.130 |
Why?
|
| Mitochondria, Heart | 1 | 2016 | 53 | 0.130 |
Why?
|
| Nanostructures | 2 | 2008 | 112 | 0.130 |
Why?
|
| Adipose Tissue | 2 | 2014 | 221 | 0.130 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 101 | 0.130 |
Why?
|
| Collagen Type I | 4 | 2012 | 175 | 0.130 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2008 | 100 | 0.130 |
Why?
|
| Soybeans | 1 | 1995 | 11 | 0.130 |
Why?
|
| Antibodies | 4 | 1997 | 241 | 0.120 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2015 | 99 | 0.120 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2013 | 144 | 0.120 |
Why?
|
| Lung | 2 | 2017 | 849 | 0.120 |
Why?
|
| Research | 2 | 2011 | 214 | 0.120 |
Why?
|
| Sodium Compounds | 1 | 2014 | 10 | 0.120 |
Why?
|
| Aluminum Compounds | 1 | 2014 | 10 | 0.120 |
Why?
|
| Ink | 1 | 2014 | 8 | 0.120 |
Why?
|
| Animals, Newborn | 3 | 2013 | 396 | 0.120 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 65 | 0.120 |
Why?
|
| Perfusion | 2 | 2006 | 131 | 0.120 |
Why?
|
| Neoplasms | 4 | 2013 | 1667 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2009 | 317 | 0.120 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2013 | 9 | 0.120 |
Why?
|
| Hydrazones | 1 | 2013 | 11 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 331 | 0.120 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2013 | 6 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 2 | 2012 | 164 | 0.120 |
Why?
|
| Biomarkers | 5 | 2021 | 1593 | 0.120 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2013 | 8 | 0.120 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2013 | 14 | 0.120 |
Why?
|
| Elastin | 3 | 2013 | 116 | 0.110 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2013 | 63 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 37 | 0.110 |
Why?
|
| Sheep | 1 | 2014 | 128 | 0.110 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 45 | 0.110 |
Why?
|
| Versicans | 2 | 2007 | 44 | 0.110 |
Why?
|
| Cell Size | 3 | 2013 | 76 | 0.110 |
Why?
|
| Equipment Design | 3 | 2016 | 500 | 0.110 |
Why?
|
| Cell Tracking | 1 | 2013 | 3 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2014 | 235 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1995 | 272 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 100 | 0.110 |
Why?
|
| Myosins | 1 | 2012 | 34 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 32 | 0.110 |
Why?
|
| Echocardiography | 3 | 2018 | 515 | 0.110 |
Why?
|
| Transferrin | 2 | 2009 | 94 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2005 | 1447 | 0.110 |
Why?
|
| Bioprosthesis | 1 | 2013 | 101 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2013 | 110 | 0.110 |
Why?
|
| Muscle Development | 1 | 2012 | 31 | 0.110 |
Why?
|
| Myxoma | 1 | 2012 | 17 | 0.100 |
Why?
|
| Epithelium | 4 | 2004 | 172 | 0.100 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2012 | 24 | 0.100 |
Why?
|
| Proteoglycans | 2 | 1997 | 103 | 0.100 |
Why?
|
| Cattle | 2 | 2003 | 475 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 3 | 2007 | 200 | 0.100 |
Why?
|
| Endocardial Cushions | 2 | 2012 | 20 | 0.100 |
Why?
|
| Protein Binding | 3 | 2010 | 1027 | 0.100 |
Why?
|
| Proteins | 3 | 2004 | 474 | 0.100 |
Why?
|
| Chondroitin | 2 | 1984 | 13 | 0.100 |
Why?
|
| Tenascin | 3 | 2003 | 39 | 0.100 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2011 | 2 | 0.100 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2011 | 12 | 0.100 |
Why?
|
| Fourier Analysis | 1 | 2011 | 31 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2008 | 2455 | 0.100 |
Why?
|
| Bioartificial Organs | 1 | 2011 | 3 | 0.100 |
Why?
|
| Materials Testing | 3 | 2014 | 263 | 0.100 |
Why?
|
| Hydrogels | 4 | 2015 | 54 | 0.100 |
Why?
|
| Male | 14 | 2019 | 37321 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 215 | 0.090 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2003 | 48 | 0.090 |
Why?
|
| Centrifugation | 2 | 2008 | 16 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 88 | 0.090 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 498 | 0.090 |
Why?
|
| Transfection | 3 | 2008 | 782 | 0.090 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 2 | 2007 | 12 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 217 | 0.090 |
Why?
|
| RNA Interference | 2 | 2010 | 266 | 0.090 |
Why?
|
| Microinjections | 3 | 2007 | 130 | 0.090 |
Why?
|
| Calorimetry, Differential Scanning | 2 | 2007 | 27 | 0.090 |
Why?
|
| Intestinal Mucosa | 2 | 2008 | 219 | 0.090 |
Why?
|
| Female | 14 | 2019 | 38074 | 0.090 |
Why?
|
| Coronary Vessels | 1 | 2012 | 313 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2010 | 34 | 0.090 |
Why?
|
| Base Sequence | 4 | 2019 | 1015 | 0.090 |
Why?
|
| Aorta | 4 | 2013 | 316 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2009 | 11 | 0.090 |
Why?
|
| Receptors, Vitronectin | 1 | 2009 | 11 | 0.090 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 15 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2001 | 191 | 0.080 |
Why?
|
| Cell Line, Tumor | 5 | 2013 | 1851 | 0.080 |
Why?
|
| Sarcomeres | 3 | 2016 | 32 | 0.080 |
Why?
|
| Biomimetic Materials | 1 | 2009 | 20 | 0.080 |
Why?
|
| NFATC Transcription Factors | 2 | 2012 | 40 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2010 | 133 | 0.080 |
Why?
|
| RNA | 2 | 2009 | 171 | 0.080 |
Why?
|
| Algorithms | 2 | 2014 | 1196 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 1033 | 0.080 |
Why?
|
| Amino Acid Sequence | 4 | 2005 | 1083 | 0.080 |
Why?
|
| Time Factors | 6 | 2019 | 4655 | 0.080 |
Why?
|
| Procollagen | 1 | 1988 | 31 | 0.080 |
Why?
|
| Extracellular Space | 4 | 1982 | 121 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 742 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2005 | 231 | 0.080 |
Why?
|
| Bromodeoxyuridine | 2 | 2010 | 37 | 0.080 |
Why?
|
| Polyethylene Glycols | 2 | 2008 | 149 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2017 | 2550 | 0.080 |
Why?
|
| Cartilage | 3 | 1993 | 51 | 0.080 |
Why?
|
| Carrier Proteins | 3 | 2009 | 597 | 0.080 |
Why?
|
| Magnetics | 1 | 2008 | 52 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2011 | 245 | 0.080 |
Why?
|
| Microscopy, Atomic Force | 1 | 2008 | 66 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 159 | 0.080 |
Why?
|
| Adenoma | 1 | 2009 | 132 | 0.080 |
Why?
|
| Cadherin Related Proteins | 2 | 2019 | 9 | 0.070 |
Why?
|
| Carotid Arteries | 2 | 2009 | 110 | 0.070 |
Why?
|
| Cell Membrane | 5 | 2013 | 525 | 0.070 |
Why?
|
| Intestines | 1 | 2008 | 114 | 0.070 |
Why?
|
| Pedigree | 2 | 2019 | 159 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 4 | 2005 | 95 | 0.070 |
Why?
|
| Cardiac Volume | 1 | 2007 | 21 | 0.070 |
Why?
|
| Software | 2 | 2015 | 418 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 132 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 261 | 0.070 |
Why?
|
| Edetic Acid | 4 | 1994 | 29 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2011 | 753 | 0.070 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2007 | 40 | 0.070 |
Why?
|
| Blood Flow Velocity | 1 | 2007 | 172 | 0.070 |
Why?
|
| Disease Progression | 2 | 2008 | 1038 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 2077 | 0.070 |
Why?
|
| Molecular Weight | 4 | 1994 | 358 | 0.070 |
Why?
|
| rho-Associated Kinases | 1 | 2006 | 32 | 0.070 |
Why?
|
| Coronary Circulation | 1 | 2007 | 136 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 3 | 2008 | 64 | 0.070 |
Why?
|
| Diazooxonorleucine | 2 | 1983 | 3 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 240 | 0.070 |
Why?
|
| Basement Membrane | 4 | 1991 | 48 | 0.070 |
Why?
|
| Fibrillins | 2 | 1997 | 24 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1070 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2007 | 77 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 434 | 0.070 |
Why?
|
| Sequence Analysis, Protein | 1 | 2005 | 16 | 0.070 |
Why?
|
| Congresses as Topic | 1 | 2006 | 85 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2016 | 2083 | 0.070 |
Why?
|
| Myosin Light Chains | 2 | 2011 | 18 | 0.070 |
Why?
|
| Dendrimers | 1 | 2005 | 12 | 0.060 |
Why?
|
| Forecasting | 1 | 2007 | 277 | 0.060 |
Why?
|
| Age Factors | 2 | 2007 | 1864 | 0.060 |
Why?
|
| Tannins | 1 | 2005 | 17 | 0.060 |
Why?
|
| Blood Banks | 1 | 2005 | 6 | 0.060 |
Why?
|
| Private Sector | 1 | 2005 | 19 | 0.060 |
Why?
|
| Cell Division | 2 | 2003 | 541 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2005 | 89 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2019 | 230 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 682 | 0.060 |
Why?
|
| Mesencephalon | 1 | 1985 | 41 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2005 | 131 | 0.060 |
Why?
|
| Hexuronic Acids | 2 | 2014 | 24 | 0.060 |
Why?
|
| Glucuronic Acid | 2 | 2014 | 25 | 0.060 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2004 | 29 | 0.060 |
Why?
|
| Sialic Acids | 2 | 1982 | 27 | 0.060 |
Why?
|
| Histocytochemistry | 5 | 1985 | 149 | 0.060 |
Why?
|
| Ethics, Medical | 1 | 2005 | 86 | 0.060 |
Why?
|
| Cell Transplantation | 1 | 2004 | 22 | 0.060 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2004 | 19 | 0.060 |
Why?
|
| Mice, Mutant Strains | 3 | 2000 | 166 | 0.060 |
Why?
|
| Tooth | 1 | 2004 | 24 | 0.060 |
Why?
|
| Skin | 1 | 2007 | 451 | 0.060 |
Why?
|
| Trisomy | 2 | 2000 | 47 | 0.060 |
Why?
|
| Azo Compounds | 1 | 1983 | 33 | 0.060 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 2003 | 10 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2003 | 11 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2003 | 6 | 0.060 |
Why?
|
| Chromatography, Affinity | 2 | 1995 | 73 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2003 | 19 | 0.060 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2003 | 22 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 689 | 0.060 |
Why?
|
| Zebrafish | 2 | 2015 | 187 | 0.060 |
Why?
|
| Neurology | 1 | 2003 | 43 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2003 | 127 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 700 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2003 | 31 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 357 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 1995 | 14 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 420 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 1753 | 0.050 |
Why?
|
| Adult | 3 | 2018 | 21403 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2003 | 248 | 0.050 |
Why?
|
| United States | 2 | 2006 | 7367 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 807 | 0.050 |
Why?
|
| Down Syndrome | 3 | 2000 | 120 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 2000 | 188 | 0.050 |
Why?
|
| Lac Operon | 1 | 2001 | 54 | 0.050 |
Why?
|
| Education, Medical | 1 | 2003 | 147 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 710 | 0.050 |
Why?
|
| Luciferases | 1 | 2001 | 105 | 0.050 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2001 | 59 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 1986 | 617 | 0.050 |
Why?
|
| Sertoli Cells | 1 | 1981 | 4 | 0.050 |
Why?
|
| Cytoskeleton | 3 | 2008 | 84 | 0.050 |
Why?
|
| Cell Self Renewal | 1 | 2021 | 13 | 0.050 |
Why?
|
| Organoplatinum Compounds | 1 | 2021 | 21 | 0.050 |
Why?
|
| Leucovorin | 1 | 2021 | 35 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2003 | 239 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 61 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2021 | 110 | 0.050 |
Why?
|
| beta-Galactosidase | 2 | 1997 | 88 | 0.050 |
Why?
|
| Lasers | 2 | 2013 | 61 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 41 | 0.050 |
Why?
|
| Alternative Splicing | 2 | 1998 | 93 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2013 | 305 | 0.050 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 2 | 2014 | 17 | 0.050 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 191 | 0.050 |
Why?
|
| Cricetinae | 4 | 2008 | 262 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2013 | 489 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2013 | 546 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2021 | 130 | 0.050 |
Why?
|
| Body Patterning | 2 | 2015 | 44 | 0.040 |
Why?
|
| Antigens, Differentiation | 2 | 1997 | 49 | 0.040 |
Why?
|
| Mitochondria | 2 | 2016 | 643 | 0.040 |
Why?
|
| GATA5 Transcription Factor | 1 | 2019 | 6 | 0.040 |
Why?
|
| Wnt3A Protein | 1 | 2019 | 6 | 0.040 |
Why?
|
| Carbohydrates | 1 | 1979 | 57 | 0.040 |
Why?
|
| Tricuspid Valve | 2 | 2012 | 42 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 29 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 56 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 1998 | 24 | 0.040 |
Why?
|
| Restriction Mapping | 1 | 1998 | 85 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 1998 | 39 | 0.040 |
Why?
|
| Genes | 1 | 1998 | 86 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 332 | 0.040 |
Why?
|
| Transforming Growth Factor beta3 | 2 | 2009 | 16 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1998 | 48 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1997 | 30 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 194 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 1997 | 25 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 135 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 1997 | 39 | 0.040 |
Why?
|
| Erythropoiesis | 1 | 1997 | 24 | 0.040 |
Why?
|
| Sulfates | 2 | 1988 | 28 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 214 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 208 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1997 | 30 | 0.040 |
Why?
|
| Lymphokines | 1 | 1997 | 49 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 2 | 2009 | 129 | 0.040 |
Why?
|
| Antigens | 2 | 1994 | 90 | 0.040 |
Why?
|
| Isomerism | 1 | 1997 | 63 | 0.040 |
Why?
|
| Erythrocytes | 1 | 1997 | 137 | 0.040 |
Why?
|
| Hyaluronan Synthases | 1 | 2017 | 21 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 282 | 0.040 |
Why?
|
| NADPH Oxidase 4 | 1 | 2017 | 17 | 0.040 |
Why?
|
| Glucuronosyltransferase | 1 | 2017 | 38 | 0.040 |
Why?
|
| Intercellular Junctions | 2 | 2013 | 32 | 0.040 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 157 | 0.040 |
Why?
|
| Erythropoietin | 1 | 1997 | 96 | 0.040 |
Why?
|
| Germ Cells | 1 | 1997 | 17 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2017 | 61 | 0.040 |
Why?
|
| Gestational Age | 3 | 2011 | 389 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 56 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 1997 | 98 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 1997 | 117 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 204 | 0.040 |
Why?
|
| Immunoblotting | 1 | 1997 | 254 | 0.040 |
Why?
|
| Kinetics | 2 | 2008 | 1047 | 0.030 |
Why?
|
| Connexin 43 | 2 | 2011 | 62 | 0.030 |
Why?
|
| CHO Cells | 2 | 2008 | 161 | 0.030 |
Why?
|
| Cell Surface Extensions | 1 | 2016 | 5 | 0.030 |
Why?
|
| Nanotubes | 1 | 2016 | 22 | 0.030 |
Why?
|
| Keratins | 1 | 1996 | 48 | 0.030 |
Why?
|
| Autoradiography | 2 | 1986 | 94 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 786 | 0.030 |
Why?
|
| Biomimetics | 1 | 2015 | 17 | 0.030 |
Why?
|
| Action Potentials | 2 | 2011 | 223 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2015 | 32 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 121 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 1995 | 14 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 219 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 90 | 0.030 |
Why?
|
| Fishes | 1 | 1995 | 77 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2010 | 756 | 0.030 |
Why?
|
| Temperature | 2 | 2005 | 341 | 0.030 |
Why?
|
| Adipocytes | 1 | 2015 | 88 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2015 | 113 | 0.030 |
Why?
|
| Organoids | 2 | 2008 | 42 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 499 | 0.030 |
Why?
|
| Heparitin Sulfate | 2 | 1996 | 20 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2013 | 42 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 21 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 37 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2013 | 45 | 0.030 |
Why?
|
| Inclusion Bodies | 1 | 1973 | 10 | 0.030 |
Why?
|
| Culture Media | 1 | 2013 | 155 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 111 | 0.030 |
Why?
|
| Porosity | 1 | 2013 | 63 | 0.030 |
Why?
|
| Wound Healing | 2 | 2013 | 260 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 60 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 562 | 0.030 |
Why?
|
| Down-Regulation | 1 | 1995 | 447 | 0.030 |
Why?
|
| DNA Primers | 2 | 2007 | 302 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.030 |
Why?
|
| Mucoproteins | 1 | 1972 | 3 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2013 | 35 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 2093 | 0.030 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2012 | 5 | 0.030 |
Why?
|
| Prostatic Neoplasms | 2 | 2010 | 778 | 0.030 |
Why?
|
| Muscles | 1 | 1993 | 158 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 397 | 0.030 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 51 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 507 | 0.030 |
Why?
|
| Peptides | 2 | 2011 | 455 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2013 | 213 | 0.030 |
Why?
|
| Transglutaminases | 1 | 2012 | 67 | 0.030 |
Why?
|
| Indoles | 1 | 2013 | 146 | 0.030 |
Why?
|
| Serotonin | 1 | 2012 | 144 | 0.030 |
Why?
|
| Cricetulus | 2 | 2008 | 98 | 0.030 |
Why?
|
| Receptor, Notch2 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Freezing | 2 | 1988 | 29 | 0.020 |
Why?
|
| AC133 Antigen | 1 | 2011 | 5 | 0.020 |
Why?
|
| Leukocyte Common Antigens | 1 | 2011 | 41 | 0.020 |
Why?
|
| Interferometry | 1 | 2011 | 6 | 0.020 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2011 | 27 | 0.020 |
Why?
|
| Onions | 1 | 2011 | 4 | 0.020 |
Why?
|
| Immune Sera | 1 | 1991 | 30 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2011 | 52 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2012 | 231 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1553 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 92 | 0.020 |
Why?
|
| Automation | 1 | 2011 | 45 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1745 | 0.020 |
Why?
|
| Hyaluronoglucosaminidase | 2 | 1985 | 43 | 0.020 |
Why?
|
| Dermis | 1 | 2010 | 29 | 0.020 |
Why?
|
| Losartan | 1 | 2010 | 45 | 0.020 |
Why?
|
| Heart Rate | 2 | 2011 | 568 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 2004 | 189 | 0.020 |
Why?
|
| Binding Sites | 2 | 2007 | 631 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2010 | 32 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 306 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 291 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 1990 | 50 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2009 | 16 | 0.020 |
Why?
|
| Enterotoxins | 1 | 1990 | 40 | 0.020 |
Why?
|
| Osteopontin | 1 | 2009 | 28 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 268 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 124 | 0.020 |
Why?
|
| Dermatan Sulfate | 1 | 1989 | 12 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 144 | 0.020 |
Why?
|
| Microchemistry | 1 | 1989 | 19 | 0.020 |
Why?
|
| Keratan Sulfate | 1 | 1989 | 12 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2009 | 30 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 1989 | 54 | 0.020 |
Why?
|
| Denervation | 1 | 1989 | 23 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 114 | 0.020 |
Why?
|
| Fetal Heart | 2 | 2000 | 41 | 0.020 |
Why?
|
| Epidermis | 1 | 1989 | 42 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 160 | 0.020 |
Why?
|
| Surface Tension | 1 | 2008 | 13 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 146 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 369 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2008 | 90 | 0.020 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2008 | 1 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1988 | 282 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Twist-Related Protein 1 | 1 | 2007 | 13 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2007 | 25 | 0.020 |
Why?
|
| Integrases | 1 | 2008 | 31 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5731 | 0.020 |
Why?
|
| Calcinosis | 1 | 2009 | 241 | 0.020 |
Why?
|
| Plastics | 1 | 1987 | 25 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 652 | 0.020 |
Why?
|
| beta Catenin | 1 | 2008 | 73 | 0.020 |
Why?
|
| Aortic Valve | 1 | 2009 | 249 | 0.020 |
Why?
|
| Pregnancy | 3 | 2000 | 2334 | 0.020 |
Why?
|
| Sulfur Radioisotopes | 1 | 1986 | 11 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 173 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 312 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 5717 | 0.020 |
Why?
|
| Adsorption | 1 | 1987 | 225 | 0.020 |
Why?
|
| Neuraminidase | 3 | 1995 | 36 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2007 | 161 | 0.020 |
Why?
|
| Gene Expression | 1 | 2009 | 770 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 791 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1985 | 42 | 0.020 |
Why?
|
| Silicon | 1 | 2005 | 20 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2006 | 108 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 7277 | 0.020 |
Why?
|
| Collagenases | 1 | 2005 | 34 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 95 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2005 | 80 | 0.020 |
Why?
|
| Transplants | 1 | 2005 | 28 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2005 | 67 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2005 | 73 | 0.020 |
Why?
|
| Elasticity | 1 | 2005 | 103 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2008 | 601 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 8912 | 0.020 |
Why?
|
| Aneurysm | 1 | 2005 | 53 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2007 | 223 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1980 | 618 | 0.020 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2005 | 21 | 0.020 |
Why?
|
| Cytokines | 1 | 2009 | 866 | 0.020 |
Why?
|
| RNA Probes | 1 | 2004 | 15 | 0.020 |
Why?
|
| Species Specificity | 1 | 2005 | 303 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2005 | 47 | 0.020 |
Why?
|
| South Carolina | 1 | 2011 | 2752 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 145 | 0.020 |
Why?
|
| Alcian Blue | 2 | 1985 | 5 | 0.020 |
Why?
|
| Odontoblasts | 1 | 2004 | 3 | 0.010 |
Why?
|
| MSX1 Transcription Factor | 1 | 2004 | 9 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2004 | 17 | 0.010 |
Why?
|
| Molar | 1 | 2004 | 27 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1987 | 370 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 246 | 0.010 |
Why?
|
| Myocardial Contraction | 2 | 1982 | 383 | 0.010 |
Why?
|
| Endocytosis | 1 | 1983 | 113 | 0.010 |
Why?
|
| Seminiferous Tubules | 1 | 1981 | 3 | 0.010 |
Why?
|
| Pseudopodia | 1 | 1981 | 16 | 0.010 |
Why?
|
| Yolk Sac | 1 | 2000 | 10 | 0.010 |
Why?
|
| Calcimycin | 1 | 1980 | 32 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 251 | 0.010 |
Why?
|
| DiGeorge Syndrome | 1 | 2000 | 13 | 0.010 |
Why?
|
| Karyotyping | 1 | 2000 | 74 | 0.010 |
Why?
|
| Aminopropionitrile | 1 | 1980 | 3 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2000 | 46 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1980 | 200 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 196 | 0.010 |
Why?
|
| Anions | 1 | 1980 | 12 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2000 | 11 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 21147 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2000 | 14 | 0.010 |
Why?
|
| Colloids | 1 | 1980 | 43 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 2000 | 31 | 0.010 |
Why?
|
| Models, Structural | 1 | 1999 | 22 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2000 | 86 | 0.010 |
Why?
|
| Syndrome | 1 | 2000 | 255 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 1979 | 7 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 2000 | 109 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2000 | 308 | 0.010 |
Why?
|
| Spleen | 1 | 2000 | 301 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 1998 | 16 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1979 | 89 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 1536 | 0.010 |
Why?
|
| Iron | 1 | 1980 | 197 | 0.010 |
Why?
|
| Gold Colloid | 1 | 1997 | 1 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1997 | 27 | 0.010 |
Why?
|
| Transgenes | 1 | 1997 | 92 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 181 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1997 | 107 | 0.010 |
Why?
|
| Mitosis | 1 | 1977 | 76 | 0.010 |
Why?
|
| Calcium | 1 | 1980 | 929 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1977 | 75 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1977 | 148 | 0.010 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1995 | 6 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1995 | 39 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1995 | 22 | 0.010 |
Why?
|
| Exons | 1 | 1995 | 122 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1995 | 136 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1995 | 167 | 0.010 |
Why?
|
| Sarcolemma | 1 | 1973 | 16 | 0.010 |
Why?
|
| Poly A | 1 | 1993 | 14 | 0.010 |
Why?
|
| Gene Library | 1 | 1993 | 68 | 0.010 |
Why?
|
| Tolonium Chloride | 1 | 1972 | 3 | 0.010 |
Why?
|
| Dioxoles | 1 | 1972 | 8 | 0.010 |
Why?
|
| Chlorides | 1 | 1972 | 68 | 0.010 |
Why?
|
| Sulfur | 1 | 1972 | 16 | 0.010 |
Why?
|
| Ferritins | 2 | 1983 | 49 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1995 | 483 | 0.010 |
Why?
|
| Magnesium | 1 | 1972 | 110 | 0.010 |
Why?
|
| DNA | 1 | 1993 | 597 | 0.010 |
Why?
|
| Lamins | 1 | 1990 | 3 | 0.010 |
Why?
|
| Ovary | 1 | 1990 | 99 | 0.010 |
Why?
|
| Preservation, Biological | 1 | 1987 | 11 | 0.000 |
Why?
|
| Laminin | 1 | 1987 | 62 | 0.000 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 1985 | 6 | 0.000 |
Why?
|
| Hematoxylin | 1 | 1985 | 8 | 0.000 |
Why?
|
| Forearm | 1 | 1985 | 25 | 0.000 |
Why?
|
| Brain | 1 | 1995 | 2176 | 0.000 |
Why?
|
| Horseradish Peroxidase | 1 | 1983 | 27 | 0.000 |
Why?
|
| Cations | 1 | 1983 | 51 | 0.000 |
Why?
|
| Muramidase | 1 | 1983 | 38 | 0.000 |
Why?
|
| Type C Phospholipases | 1 | 1982 | 67 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1981 | 122 | 0.000 |
Why?
|
| Germ Layers | 1 | 1980 | 4 | 0.000 |
Why?
|